Zobrazeno 1 - 8
of 8
pro vyhledávání: '"C. H. M. van Deurzen"'
Autor:
M. Lagendijk, E. L. Vos, A. H. J. Koning, M. G. M. Hunink, J. P. Pignol, E. M. L. Corten, C. de Monye, C. H. M. van Deurzen, J. H. van Dam, W. W. Vrijland, C. M. E. Contant, C. Verhoef, W. van Lankeren, L. B. Koppert
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-7 (2017)
Abstract Background Cosmetic result following breast conserving surgery (BCS) for cancer influences quality of life and psychosocial functioning in breast cancer patients. A preoperative prediction of expected cosmetic result following BCS is not (ye
Externí odkaz:
https://doaj.org/article/a484d3fb46ef4f53bb52830b6005d028
Autor:
C. H. M. van Deurzen, R. van Hillegersberg, M. G. G. Hobbelink, C. A. Seldenrijk, R. Koelemij, P. J. van Diest
Publikováno v:
Cellular Oncology, Vol 29, Iss 6, Pp 497-505 (2007)
Background: The need for routine axillary lymph node dissection (ALND) in patients with invasive breast cancer and low-volume sentinel node (SN) involvement is questionable. Accurate prediction of second echelon lymph node involvement could identify
Externí odkaz:
https://doaj.org/article/d7f06f96c9064a9aa4e1a1e8ceeecea8
Autor:
S, Moghadasi, V, Grundeken, L A M, Janssen, N H, Dijkstra, M, Rodríguez-Girondo, W A G, van Zelst-Stams, J C, Oosterwijk, M G E M, Ausems, R A, Oldenburg, M A, Adank, E W, Blom, M W G, Ruijs, T A M, van Os, C H M, van Deurzen, J W M, Martens, C P, Schroder, J T, Wijnen, M P G, Vreeswijk, C J, van Asperen
Publikováno v:
Clinical genetics. 93(1)
To establish whether existing mutation prediction models can identify which male breast cancer (MBC) patients should be offered BRCA1 and BRCA2 diagnostic DNA screening, we compared the performance of BOADICEA (Breast and Ovarian Analysis of Disease
Autor:
S. E., Pinder, C. H. M., van Deurzen, L. C., Collins, D. L., Weaver, S. B., Fox, J., Wesseling, S. J., Schnitt
Publikováno v:
WHO/IARC Classification of Tumours; 2019, p76-81, 6p
Publikováno v:
Journal of microscopy. 249(2)
In traditional cancer diagnosis, (histo)pathological images of biopsy samples are visually analysed by pathologists. However, this judgment is subjective and leads to variability among pathologists. Digital scanners may enable automated objective ass
Publikováno v:
WHO/IARC Classification of Tumours; 2019, p284-285, 2p
Publikováno v:
WHO/IARC Classification of Tumours; 2019, p121-122, 2p
Publikováno v:
WHO/IARC Classification of Tumours; 2019, p119-120, 2p